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Robin M Hallett1 and Tracy Chew2,3*Abstract
Background: The objective of this study was to identify leukocyte cell types found within the synovia of patients
with seronegative spondylarthropathies (SpA), such as ankylosing spondylitis (AS), using transcription based
analyses.
Methods: Leukocyte transcriptional profiles obtained from the NCBI’s gene expression omnibus and prediction
analysis of microarrays (PAM) was used to identify 25-gene leukocyte metagenes. Subsequently, transcriptional
profiles from murine and clinical models of AS and SpA were interrogated to characterize the local infiltration
of leukocytes in SpA synovia.
Results: Analysis of a proteoglycan-induced murine model of AS reveals infiltration of dendritic cells, CD4+ T cells,
monocytes, and natural killer cells to the spine. In human SpA and AS patients, transcriptional analysis of synovial
biopsies revealed local infiltration of dendritic cells and CD4+ T cells.
Conclusions: We identified leukocyte cell types that infiltrated the synovial of SpA patients. Our results imply a role
for dendritic cells and CD4+ T cells in the local inflammation that underlies pathogenesis in patients with SpA.
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Spondyloathropathies (SpA) represent a spectrum of in-
flammatory and degenerative joint diseases affecting the
spine, with ankylosing spondylitis (AS) being among the
most prevalent and debilitating worldwide. Primary mani-
festations of SpA involve axial manifestations such as
sacroiliitis, and include both musculoskeletal and extra-
articular symptoms. AS in particular is characterized by a
variety of inflammatory conditions including joint and
back pain, with severe cases progressing to spinal fusion
and kyphosis leading to restricted mobility. While the dis-
ease is known to be inflammatory in nature, the specific
mechanisms and cell types triggering inflammation within
the joint are less well characterized.* Correspondence: tchew@cmcc.ca
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article, unless otherwise stated.Several genome-wide association studies and gene ex-
pression studies have been performed in AS and SpA pa-
tients, revealing several lines of evidence regarding the
mechanisms of inflammation underlying disease [1-3].
Importantly, several important cellular processes have
been implicated in the immune-mediated pathogenesis
of AS, including antigen processing, the tumor necrosis
factor alpha (TNFα)/nuclear factor kappa beta (NFκΒ)/
interleukin 1 beta (IL-1β) axis, and the IL-23/IL-17/T
helper 17 (Th17) axis. Serum TNFα and IL-6 levels correl-
ate positively with disease [4], and TNFα inhibitors are the
primary course of treatment for AS patients. In addition,
the association of IL12B and IL23R genes in AS patients,
as well as elevated serum and synovial levels of IL-17-
related gene products suggests a role for the Th17/IL-23/
IL-17 axis in pathology [5]. Importantly, these observa-
tions were derived from serological studies, and do not de-
lineate local changes in a joint that may directly reflect
important inflammatory processes underlying disease.ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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cesses specifically occur within the synovia that are associ-
ated with joint/spinal inflammation, and which cell types
are responsible for inflammatory cytokine production. To
date, only a handful of studies have implicated a role for
specific immune cell types involved in the inflammatory
response in the joints of AS patients. The detection of
FoxP3+ CD4+ T cells, IL-17-producting T cells, and
KIR3DL2+ Th17 cells in the synovial fluid of patients with
AS and with SpA implies a role for regulatory T cells in the
local inflammatory processes in the joint [6-8]. Addition-
ally, some early evidence of local infiltration of mast cells
and phagocytic monocytes in the knee of AS patients by
microscopy implies a role for these immune cell types in
the local tissue [9]. However, this observation has not been
validated by more comtemporary quanititative measures
such as flow cytometry. Additional cells types associated
with inflammation have been identified in the peripheral
blood, but fail to delineate a relationship to the local in-
flammatory milieu [5,10-13].
Importantly, gene expression profiles have been con-
ducted from the synovial fluid of AS patients and from
mouse models of AS. Given the availability of gene expres-
sion profiles from purified leukocyte populations as well
as from the synovial biopsies of AS and SpA patients, we
sought to identify the immune cell subtypes infiltrating
the local inflammatory milieu of these patients.
Methods
Patients and samples
All data were publicly available and downloaded from the
gene expression omnibus (GEO, http://www.ncbi.nlm.nih.
gov/geo/). The leukocyte (GSE1133 & GSE22886), mouse
AS (GSE41039) and patient biopsy (GSE41038) datasets
were downloaded and processed independently [14-17].
For Affymetrix data, the raw .CEL files comprising each
dataset were download and normalized using the Robust
Multichip Algorithm (RMA) to generate probe set in-
tensities [18]. For Illumina data, normalized data was
downloaded directly from GEO. All human data were
downloaded from a publicly available database, and
were previously published. No new patients or samples
were collected for this study.
Prediction analysis of microarrays (PAM)
PAM was downloaded as an excel add-in from http://
www-stat.stanford.edu/~tibs/PAM/, and was used ac-
cording to the available manual. Briefly, we used this al-
gorithm to interrogate the human leukocyte series for the
top 25 class genes where each different population of puri-
fied leukocytes was an independent class. Leukocyte class
assignment was made as follows: Monocytes (GSM18871 &
18872), DCs (GSM18873 & 18874), NK cells (GSM18875
& 18876), CD4+ T cells (GSM18877 & 18878), CD8+T cells (GSM18879 & 18880), and B cells (GSE18881
& 18882).
Evaluation of leukocyte metagenes
For cross-platform comparisons, datasets were collapsed to
single genes based on highest mean average and mapped
based on Unigene ID. To evaluate leukocyte metagenes,
the expression values for each gene was transformed such
that the mean and standard deviation were set to 0 and 1
in each dataset, respectively. A metagene score was calcu-





where x is the transformed expression, n is the number of
genes in class set P and P is the set of class marker genes
for a particular metagene [19-21].
Statistical analysis
T-tests were used to compare indices between control
and spondylarthropathy samples in both murine and hu-
man datasets. All tests were two-sided and a p-value of
0.05 or less was considered statistically significant.
Results
Identification of leukocyte expression metagenes
Whereas the underlying mechanisms behind AS and other
SpA are known to be inflammatory in nature, the specific
leukocyte cell populations that drive inflammation are un-
known. Hence, we sought to measure infiltration of spe-
cific leukocyte cell populations within synovial biopsies of
experimental and clinical models of AS and SpA. To this
end, we identified leukocyte transcript modules, which
could be implemented to measure leukocyte infiltration
in patient biopsies for which the global gene expression
profile is known. Based on publicly available global gene
expression profiling data of the human transcriptome, we
identified samples representing multiple purified leukocyte
cell populations including monocytes, dendritic cells (DC),
B cells, natural killer (NK) cells, CD4+ T cells and CD8+
T cells. We used PAM [22] to identify a gene expression
based classifier that could discriminate between leukocyte
cell type according to patterns in gene expression. Briefly,
PAM is an efficient tool to identify molecular patterns
that is applicable to gene expression data, and uses nearest
shrunken centroids to identify subsets of genes that best
characterize sample classes. We used PAM to identify a
150 gene classifier that comprised the top 25 marker genes
associated with each leukocyte cell type (see Additional
file 1: Table S1). This composite gene signature is known
as a metagene, and gene clusters representing each
leukocyte metagene is shown in Figure 1A. To test whether
the expression of each leukocyte metagene was highly
Figure 1 Gene expression measurements uniquely identify immune cell subsets. (A) Expression of top 25 specific immune cell transcripts
among various preparations of purified immune cells. (B) Heatmap representation of immune metagene scores calculated from the top 25
specific immune cell transcripts for each cell type. (C) Scatter plot of subtype-specific metagene scores for each purified immune cell subtype.
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we calculated immune cell metagene scores for each cell
type across all cell types (Figures 1B and C). For example,
the average monocyte metagene score was highest in the
purified monocyte cell population, and negative in each
other leukocyte population. Although we observed some
cross-specificity between the CD4 and CD8 T cell signa-
tures, the leukocyte metagene score was highest in the
target cell population for each leukocyte cell type, sup-
porting the overall validity of the approach. To fur-
ther validate this approach we downloaded additional
independent gene expression profiles from purified
leukocyte populations and tested the capacity of the
various metagenes to accurately discriminate between the
cell types [17]. Importantly, the metagene signatures were
sufficient to stratify these various leukocyte cell types (see
Additional file 2: Figure S1). Based on these data, we con-
cluded that leukocyte metagene signatures could beimplemented to measure infiltration of specific leukocyte
cell populations in patient biopsies.
Leukocyte metagenes identify local infiltration of multiple
leukocyte subsets in a murine model of AS
Although the overarching objective of this work was to
was identify populations of leukocytes that might mediate
inflammation in human patients with either AS or SpA,
we first sought to examine the expression of leukocyte
metagenes in a mouse model of AS. In this case, the mouse
model offers several advantages over the human samples,
including samples being harvested from mice with identi-
cal genetic backgrounds, as well as whole spine samples
being obtained for global gene expression profiles. Briefly,
we downloaded publicly available gene expression profiles
of control (n = 4) and experimental (n = 4) mouse spines
based on the proteoglycan-induced AS model in BALB/c
mice [23]. We observed expression differences between
Hallett and Chew BMC Musculoskeletal Disorders 2014, 15:446 Page 4 of 7
http://www.biomedcentral.com/1471-2474/15/446control and experimental mice for several of the leukocyte
metagenes (Figure 2A). Specifically, we observed increased
monocyte, DC, NK, and CD4+ T cell metagene expression
within the spines of mice induced with experimental AS
(Figure 2B). Hence, we conclude that in an experimental
mouse model of AS, the disease is associated with in-
creased monocyte, DC, NK cells, and CD4+ T cell infiltra-
tion relative to control animals.
Leukocyte metagenes identify differential leukocyte
infiltration in synovial biopsies of patients with
seronegative SpA
To extend these findings in human patients, we examined
the expression of leukocyte metagenes in synovial biopsies
extracted from patients with seronegative SpA or in con-
trol biopsies. Briefly, we downloaded publicly available
gene expression profiling data for the samples described
above, and compared leukocyte metagene expression in
biopsies derived from the 8 SpA patients (2 AS, 6 SpA)
with 7 control biopsies (4 normal, 3 OA). Similar to the
mouse model data, we observed differences in leukocyte
metagene expression among the control and SpA patient
biopsies (Figure 3A). Specifically, we observed increasedMonocyte score
Dendritic cell score
NK cell score
CD4 T cell score











Figure 2 Synovial biopsies of AS mice contain increased numbers of
representation of immune metagene scores from synovial biopsies of c
subtype-specific metagene scores from synovial biopsies of control or
control for a given leukocyte subset by student’s T-test.DC and CD4+ T cell metagene expression in the SpA
biopsies relative to control biopsies (Figure 3B). Interestingly,
we did not observe increased expression of monocyte and
NK cell metagene expression in the human SpA biopsies
relative to control, whereas these metagenes were signifi-
cantly more highly expressed in experimental mouse biop-
sies. A post-hoc analysis of individual genes comprising
the differentially expressed leukocyte metagenes, revealed
that metagenes were upregulated as a whole, and the ob-
served increases were not driven by dramatic up-regulation
relatively few genes (see Additional file 3: Figure S2). Im-
portantly, this suggests that our observations are not con-
founded by dramatic changes in single genes, and likely
represent true measurements of infiltration.
Taken together with our previous data, these findings
strongly suggest that the joints of patients with AS/SpA
contain increased leukocyte infiltrate that primarily com-
prises DC and CD4+ T cells relative to control patient
joints.
Discussion
This study identifies infiltrating leukocyte subtypes within
the local tissue of patients suffering from seronegativemonocytes, dendritic cells, NK cells, and CD4+ T cells. (A) Heatmap
ontrol mice or peptidoglycan-induced AS mice. (B) Scatter plot of
AS mice. *indicates statistical significance between AS biopsies and
Figure 3 Synovial biopsies of AS and seronegative spondylarthropathy (SpA) patients contain increased numbers of dendritic cells and
CD4+ T cells compared to control patients. (A) Heatmap representation of immune metagene scores from synovial biopsies of control donors
or AS/SpA patients. (B) Scatter plot of subtype-specific metagene scores from synovial biopsies of control donors or AS/SpA patients. *indicates
statistical significance between AS biopsies and control for a given leukocyte subset by student’s T-test.
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leukocyte cell types found in peripheral blood to their in-
filtration within the local inflammatory milieu of the joints
in these patients. Previous studies identified increased
numbers of IL-17- and IL-22-producing CD4+ T cells [5,10],
but their specific role in the pathogenesis of disease re-
mains unclear. Furthermore, their presence within the
synovial of inflamed joints in the spine has not been eluci-
dated. As gene expression profiles of specific T cell sub-
sets, including Th17, γ/δ, and regulatory T cells, is not
available, this study is not able to distinguish these specific
T cell subsets. An interrogation of these cell types in the
local tissue would be an important follow-up study, as a
number of T cell subsets have been implicated in disease
from peripheral blood analyses.
Previous studies also identified various biomarkers in
the peripheral blood of AS patients that correlate with
disease. For example, Bal et al. [4] demonstrate that AS
patients have increased circulating levels of TNFα; inter-
estingly, monocyte-derived DCs and macrophages are an
important source of TNFα and play a crucial role in the
initiation of a local inflammatory response. Additionally,
several TNFα-related genes have been identified in the
positively correlated immune cell subsets, implying an
important role for this pathway in immune pathogenesis
of disease. Although we did not observe significantlyincreased expression of monocyte markers in SpA pa-
tients, a proportion of the patients in this sample set did
exhibit increased monocyte metagene expression.
Whether this trend would be statistically significant in a
larger sample size is unclear. Together with the observa-
tion that monocytes were found at increased levels in a
mouse model of AS, it is clear that infiltrating monocytic
cells including monocyte-derived DCs are associated with
the disease state. Similarly, we have shown here that pro-
fessional antigen presenting cells including monocyte-
derived cells and DCs are upregulated in AS synovial, as
previously observed in peripheral blood. Interestingly,
DCs have been shown to be a source of elevated serum
ERAP1 expression in AS patients, implying a dysfunc-
tional role of DCs in antigen presentation leading to in-
flammation [24]. Finally, the IL-23/Th17/IL-17 axis has
been implicatied in AS pathogenesis [1-3]. Here, we report
increased levels of CD4+ T cells in within the synovial
fluid of AS/SpA patients. Whether these cells also express
IL-17, or include Th17 cells, is not clear, as transcriptional
profiles of purified Th17 cells are not available for meta-
analysis of this type.
Importantly, immune pathways previously identified to
underlie AS pathogenesis have not been identified in the
local environment in our analysis. For example, Baek
et al. observed increased levels of IL-4+ CD8+ T cells in
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we do not observe CD8+ T cells levels within the syno-
via, implying that this cell type may not play as import-
ant a role in the local tissue as it does in the periphery.
Additionally, a recent identification of abzymes (anti-
bodies with catalytic activity) has been correlated to SpA
[25], despite the absence of B cells within the local tis-
sue. Indeed, extra-articular symptoms of AS and other
SpA may involve such cell types; whether these cell types
infiltrate the local environment of an extra-articular site
of inflammation is an important question and remains
unclear.
Conclusions
Our data suggest that local inflammatory processes under-
lying SpA cannot be deduced based on biomarkers identi-
fied in peripheral blood. While peripheral blood markers
serve as important diagnostic tools, the local environment
is responsible to eliciting inflammation within the joint
and should be the basis for pharmacological interventions.
Therefore, a closer investigation of the local inflammatory
responses underlying a variety of inflammatory arthritic
diseases, including AS/SpA, is an important first step in
understanding and targeting pathways involved in patho-
genesis of disease.
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